Every month, MassBio spotlights a member company and the great work they’re doing to advance the life sciences industry and support the patients we serve. In August, we spoke with Emilio A. Emini, Ph.D., CEO of The Bill & Melinda Gates Medical Research Institute. Emilio leads Gates MRI’s research and development of novel products and interventions for diseases disproportionately impacting the world’s most vulnerable populations. Before joining the institute, Emilio served as director of the Tuberculosis and HIV program at the Bill & Melinda Gates Foundation, where he led the foundation’s efforts focused on accelerating the reduction in the incidence of HIV and TB in high-burden geographies. He previously enjoyed a 30-year career in the biopharmaceutical industry, leading R&D teams at the Merck Research Laboratories and at Pfizer Inc.